Endocrine oncology

Perineural Invasion Is Not an Independent Risk Factor for Recurrence and Lateral Neck Metastasis in Thyroid Cancer: A Propensity Score Matching Analysis

Endocr PractPublished Retrospective cohort study

Authors' conclusion

The PNI in thyroid cancer was associated with higher recurrence rates and increased N1b. However, it was not considered a significant independent risk factor for recurrence or N1b. Further research is needed to refine the management strategies for patients with PNI to improve prognosis.

Study context

Population
Patients with thyroid cancer who underwent surgery, January 2000 to December 2020, Seoul St. Mary's Hospital
Participants
8,572 patients
Exposure
Perineural invasion (PNI) vs no PNI
  • PNIn = 144
Outcome
Recurrence and lateral neck lymph node metastasis (N1b)
Methodological detailspropensity score matching, single-centre
  • Propensity score matching
  • Single-centre

Main finding

As reported in the abstract

Recurrence rate
  • Recurrence rates higher with PNI before (11.1% vs 5.6%) and after propensity score matching (PSM) (11.3% vs 5.6%)
  • PNI a significant risk factor for recurrence in Cox regression before PSM but not after PSM
  • PNI a significant risk factor for N1b in univariate logistic regression but not in multivariate analysis, before and after PSM
  • PNI vs No PNI: before PSM: 11.1% vs 5.6%; after PSM: 11.3% vs 5.6%

Observational data: associations, not effects.

Further findings

Prevalence of PNI

Patients with PNI
144 (1.7%)

Clinicopathologic characteristics

PNI had higher rates of gross extrathyroidal extension, vascular and lymphatic invasion, and advanced TNM stage

Original publication

Perineural Invasion Is Not an Independent Risk Factor for Recurrence and Lateral Neck Metastasis in Thyroid Cancer: A Propensity Score Matching Analysis. Endocr Pract. Published 3 June 2025. doi:10.1016/j.eprac.2025.05.747

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.